Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$26.25 0.15 (0.57%) as of 4:30 Fri 4/19


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.30(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.1 - $47.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 201,796 301,022
Total Sell Value $3,656,226 $3,656,226 $6,836,738 $12,842,588
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 36 60
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 266
  Page 4 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 AS $48.92 $978,400 D/D (20,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 OE $1.61 $32,200 D/D 20,000 20,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-09-30 4 AS $46.74 $467,400 D/D (10,000) 5,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-09-30 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Stack David M President and CEO   •       •      –    2013-09-30 4 AS $47.01 $705,741 D/D (15,000) 2,573     -
   Stack David M President and CEO   •       •      –    2013-09-30 4 OE $1.61 $24,150 D/D 15,000 17,573     -
   Longenecker John P Phd Director   –       •      –    2013-09-30 4 AS $46.74 $116,850 D/D (2,500) 0     -
   Longenecker John P Phd Director   –       •      –    2013-09-30 4 OE $1.61 $4,025 D/D 2,500 2,500     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-09-25 4 AS $47.00 $470,000 D/D (10,000) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-09-25 4 OE $5.49 $54,900 D/D 10,000 10,000     -
   Kronenfeld Mark A. Director   –       •      –    2013-09-11 4 B $37.01 $37,010 D/D 1,000 1,000 2.39     -
   Wicki Andreas Director   –       •      –    2013-09-11 4 S $37.25 $662,417 I/I (17,783) 1,692,194     -
   Wicki Andreas Director   –       •      –    2013-09-11 4 OE $2.69 $662,390 I/I 79,033 1,707,291     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-08-14 4 AS $37.00 $543,900 D/D (14,700) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-08-14 4 OE $1.61 $23,667 D/D 14,700 14,700     -
   Wicki Andreas Director   –       •      –    2013-07-22 4 AS $35.28 $703,508 I/I (19,938) 1,630,944     -
   Wicki Andreas Director   –       •      –    2013-07-19 4 AS $34.98 $1,959,524 I/I (56,020) 1,650,882     -
   Wicki Andreas Director   –       •      –    2013-07-18 4 AS $34.80 $140,662 I/I (4,042) 1,706,902     -
   Wicki Andreas Director   –       •      –    2013-07-17 4 AS $33.20 $714,398 I/I (21,518) 1,710,944     -
   Wicki Andreas Director   –       •      –    2013-07-16 4 AS $33.20 $11,620 I/I (350) 1,732,462     -
   Wicki Andreas Director   –       •      –    2013-07-15 4 AS $33.28 $1,601,833 I/I (48,132) 1,732,812     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-07-12 4 AS $32.00 $952,128 D/D (29,754) 0     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-07-12 4 OE $1.61 $47,904 D/D 29,754 29,754     -
   Wicki Andreas Director   –       •      –    2013-07-11 4 AS $31.48 $2,518,416 I/I (80,000) 1,780,944     -
   Wicki Andreas Director   –       •      –    2013-07-05 4 AS $30.80 $1,355,961 I/I (44,021) 1,860,944     -
  266 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us